Screener
Edgewise Therapeutics, Inc. EWTX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
FAQ
- What is Edgewise Therapeutics, Inc.'s shares (diluted)?
- Edgewise Therapeutics, Inc. (EWTX) reported shares (diluted) of 107.1M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Edgewise Therapeutics, Inc.'s shares (diluted) increased by 12.6% year-over-year, from 95.1M to 107.1M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s shares (diluted) has grown at a 31.3% compound annual growth rate (CAGR), from 137.6M to 408.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Edgewise Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude